What is the Vascular Dementia Market?
DelveInsight’s ‘Vascular Dementia Market Insights, Epidemiology, and Market Forecast–2032’ report deliver an in-depth understanding of the Vascular Dementia, historical and forecasted epidemiology as well as the Vascular Dementia market trends in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom) and Japan.
Know which Vascular Dementia Therapy is expected to score the touchdown first- Vascular Dementia Market
What is the Vascular Dementia Market Report?
The Vascular Dementia market report provides current treatment practices, emerging drugs, and market share of individual therapies, current and forecasted 7MM Vascular Dementia market size from 2019 to 2032. The Report also covers current Vascular Dementia treatment practice, market drivers, market barriers, SWOT analysis, reimbursement and market access, and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the market.
Get an Exclusive Copy of the Report Here- Vascular Dementia Market Forecast
What is the Vascular Dementia Overview?
The word dementia describes a set of symptoms that can include memory loss and difficulties with thinking, problem-solving, or language. In vascular dementia, these symptoms occur when the brain is damaged because of problems with blood supply to the brain. Vascular dementia is an etiological category of dementia characterized by severe cognitive impairment resulting from ischemic or hemorrhagic stroke or hypoperfusion affecting brain regions important for memory, cognition, and behavior. Vascular dementia is a decline in thinking skills caused by conditions that block or reduce blood flow to various brain regions, depriving them of oxygen and nutrients. Cognition and brain function can be significantly affected by the size, location, and the number of vascular changes.
A growing number of experts prefer the term “vascular cognitive impairment” (VCI) to “vascular dementia” because they feel it better expresses the concept that vascular thinking changes can range from mild to severe. According to the Vascular Impairment of Cognition Classification Consensus Study (VICCCS) guideline, Vascular Dementia can be classified into four major subtypes: Post-stroke dementia (PSD) defined as dementia manifesting within 6 months after a stroke; Subcortical ischemic vascular dementia (SIVAD); Multi-infarct (cortical) dementia; and mixed dementia. Vascular Dementia is caused by different conditions that interrupt the flow of blood and oxygen supply to the brain and damage blood vessels in the brain.
What about the Vascular Dementia Diagnosis and Treatment?
The diagnosis of vascular dementia should be suspected in patients with significant vascular risk factors, stroke, or heart disease who exhibit abrupt changes in cognition. Brain imaging demonstrating the presence of relevant lesions of cerebrovascular disease is crucial for diagnosing vascular dementia.
In Vascular dementia decreased blood flow damages brain tissue. Blood flow to brain tissue may be reduced by a partial blockage or completely blocked by a blood clot. Currently, there is no cure for the condition or a way to reverse the damage already happened. But, treatment can help prevent further damage to the brain in people with vascular dementia and may slow down its progression.
Vascular Dementia Epidemiology Insights in the 7MM
The disease epidemiology covered in the report provides historical as well as forecasted epidemiology segmented by total prevalent cases of dementia, diagnosed prevalent cases of dementia, diagnosed prevalent cases of vascular dementia and age-specific diagnosed prevalent cases of vascular dementia in scenario of Vascular Dementia in the 7MM covering the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom) and Japan from 2019 to 2032.
Vascular Dementia Key Findings
· As per the assessment of DelveInsight, total prevalent cases of dementia in the 7MM were found to be 21,591,565 in 2021, which are expected to increase at a Compound Annual Growth Rate (CAGR) of 2.42% during study period.
· The diagnosed prevalent cases of dementia in the 7MM were found to be 11,344,408 in 2021, which are expected to increase at a CAGR of 3.60% for the study period of 2019-2032.
· As per DelveInsight estimates, 7MM accounts for 2,795,390 diagnosed prevalent cases of Vascular Dementia in 2021, which are expected to increase at a CAGR of 3.60%.
· Among 7MM, the United States has the highest diagnosed cases of Vascular Dementia with 1,110,606 cases in 2021, equivalent to 40% of total diagnosed prevalent cases in the 7MM.
· Vascular Dementia is highly prevalent in age group of 60 years and above, while below this age group the disease appears to be rare. Thus, we have stratified diagnosed prevalence cases in the age group of 60–70 years, 71–80 years, 81–90 years, and ≥91 years.
· In 2021, the EU-5 accounts for 893,124 diagnosed prevalent cases of Vascular Dementia, which will increase by 2032 at a CAGR of 3.26%.
· In 2021, Japan had 791,660 diagnosed cases of Vascular Dementia ranking second-highest among 7MM. These cases are expected to increase by 2032 at a CAGR of 3.37% during the forecasted period (2022–2032).
For further information on Market Impact by therapies, download Vascular Dementia Market Sample @ Vascular Dementia Market Size
Key Questions Vascular Dementia Market Insight Report
· What was the Vascular Dementia market share (%) distribution in 2019 and how it would look like in 2032?
· What would be the Vascular Dementia total market size as well as market size by therapies across the 7MM during the forecast period (2022–2032)?
· What are the key findings pertaining to the market across the 7MM and which country will have the largest Vascular Dementia market size during the forecast period (2022–2032)?
· At what CAGR, the Vascular Dementia market is expected to grow at the 7MM level during the forecast period (2022–2032)?
· What would be the Vascular Dementia market outlook across the 7MM during the forecast period (2022–2032)?
· What would be the Vascular Dementia market growth till 2032 and what will be the resultant market size in the year 2032?
· How would the market drivers, barriers and future opportunities affect the market dynamics and subsequent analysis of the associated trends?
What are the Vascular Dementia Market Companies?
Some of the key players of the Vascular Dementia market includes Eisai Inc., Ever Neuro Pharma GmbH, Geny Research Corp, Novartis, Charsire Biotechnology Corp, Merz Pharmaceuticals GmbH, LLC Merz Pharma, Otsuka Pharmaceutical Co., Ltd, Johnson & Johnson Pharmaceutical Research & Development LLC, and many others
Discover more about therapy set to grab substantial Vascular Dementia Market Landscape @ VascularDementia Market Share
Table of content
1. Key Insights
2. Report Introduction
3. Vascular Dementia Market Overview at a Glance
4. Vascular Dementia Market: Future Perspective
5. Executive Summary of Vascular Dementia
6. Key Events
7. Disease Background and Overview
8. Epidemiology and Patient Population
9. Patient Journey
10. Emerging Drugs
11. Vascular Dementia: Seven Major Market Analysis
12. KOL Views
13. Vascular Dementia Market Drivers
14. Vascular Dementia Market Barriers
15. SWOT Analysis
16. Unmet Needs
17. Reimbursement and Market Access
18. Appendix
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
Get to know more information about the market share of Vascular Dementia treatment therapies @ VascularDementia Market Companies
Recently Launched Market Research Reports 2022 by DelveInsight
- Cataract Surgery Complications Market Trend
- Oncolytic Virus Cancer Therapy Pipeline
- Medical Marijuana Market
- AL Amyloidosis Market
- Ranibizumab Biosimilars Insight
- Systemic Mastocytosis Market
- Trichomoniasis Market
- Temporomandibular Disorders Market
- Alpha Thalassemia Market
- Membranous Nephropathy Market
- Orthopedic Power Devices Market
- Urethral Stricture Treatment Devices Market
- Lice Infestations Market
- Ocular Hypertension Market
- Wolman Disease Market
- Acute Myeloid Leukemia Market
- Open-Angle Glaucoma Market
- Tay-Sachs Disease Market
- Vulvovaginal Candidiasis Market
- Gastritis Market
- Japan Healthcare Outlook Market
- Behcet’s Disease Market
- Lambert-Eaton Myasthenic Syndrome Market
About Us
DelveInsight is a Business Consulting and Market research company, providing expert business solutions for the healthcare domain and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers & Acquisitions
